Back to search

Article

Advancing AAV production with high-throughput screening and transcriptomics

2024-06-18

Abstract excerpt

AAV is a widely used vector for in vivo gene delivery that often requires considerable manufacturing capacity. However, current manufacturing techniques are inefficient, leading to high production costs and product impurities that could limit efficacy and risk patient safety. These factors severely limit the widespread use of AAV-mediated gene therapies for common and rare indications. To develop, manufacture, and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3bec9099-2d52-5940-be7c-c92013abab85
DOI
10.18609/cgti.2024.095
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Advancing AAV production with high-throughput screening and transcriptomicsDOI 10.18609/cgti.2024.095
Unravelling the essential elements for recombinant adeno-associated virus (rAAV) production in animal cell-based platformsSemantic proximity
Analytical methods for process and product characterization of recombinant adeno-associated virus-based gene therapiesSemantic proximity
AAV-Based Gene Therapy: Opportunities, Risks, and Scale-Up StrategiesSemantic proximity
Recent advances in upstream process development for production of recombinant adeno‐associated virusSemantic proximity
Critical challenges and advances in recombinant adeno‐associated virus (rAAV) biomanufacturingSemantic proximity
Transcriptomics-informed pharmacology identifies epigenetic and cell cycle regulators as enhancers of AAV productionSemantic proximity
High‐yield recombinant adeno‐associated viral vector production by multivariate optimization of bioprocess and transfection conditionsSemantic proximity
Molecular design for recombinant adeno-associated virus (rAAV) vector productionSemantic proximity
CRISPR screen for rAAV production implicates genes associated with infectionSemantic proximity
Overcoming Bottlenecks in AAV Manufacturing for Gene TherapySemantic proximity
AAV vector manufacturing process design and scalability - Bending the trajectory to address vector-associated immunotoxicitiesSemantic proximity
Gene therapy: challenges in cell culture scale-upSemantic proximity
Select a neighboring publication to make it the new centre.